Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oral bacterial surface components and volatile sulfur compounds (VSCs) represent a complex group of biological and chemical entities involved in oral health and disease. Bacterial surface components, such as fimbriae and lipopolysaccharides, are critical for the adhesion of pathogens to oral tissues and the formation of complex biofilms known as dental plaque (PubMed: 20643938). Volatile sulfur compounds, primarily hydrogen sulfide and methyl mercaptan, are produced by anaerobic bacteria during the proteolytic degradation of sulfur-containing amino acids (StatPearls: Halitosis). These compounds are the primary cause of halitosis and have been shown to be toxic to gingival tissues, potentially exacerbating periodontal disease by increasing mucosal permeability (Journal of Breath Research, 2013). Therapeutic strategies targeting these entities include the use of antimicrobial agents like chlorhexidine to reduce bacterial populations and metal ions like zinc to chemically neutralize VSCs. Effective management of these targets is essential for treating oral malodor and maintaining periodontal health.
Antimicrobial agents reduce the bacterial load and inhibit the enzymatic pathways responsible for sulfur metabolism, while metal ions like zinc chemically react with volatile sulfur compounds to form stable, non-volatile precipitates, thereby neutralizing oral malodor.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oral bacterial surface components and volatile sulfur compounds (VSC).